John Alexander Kelly
Chief Financial Officer · 3 filings · Latest: Jun 1, 2026
PRECISION BIOSCIENCES INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
DTIL | John Alexander Kelly | Chief Financial Officer | Feb 18, 2026 | Sale | $3.84 | 8,149 | $31.3K | 125,883 | |
DTIL | John Alexander Kelly | Chief Financial Officer | Feb 17, 2026 | Option Exercise | $0.00 | 27,584 | — | 134,032 | |
DTIL | Kelly John Alexander | — | Feb 18, 2026 | Proposed Sale | $3.84 | 8,149 | $31.3K | — | |
DTIL | John Alexander Kelly | Chief Financial Officer | Jan 21, 2026 | Sale | $4.03 | 15,213 | $61.3K | 106,448 | |
DTIL | John Alexander Kelly | Chief Financial Officer | Jan 20, 2026 | Option Exercise | — | 44,363 | — | 121,661 | |
DTIL | Kelly John Alexander | — | Jan 21, 2026 | Proposed Sale | $4.03 | 15,213 | $61.3K | — | |
DTIL | Kelly John Alexander | — | Nov 3, 2025 | Proposed Sale | $6.49 | 1,303 | $8.5K | — | |
DTIL | Kelly John Alexander | — | Jul 3, 2025 | Proposed Sale | $4.26 | 14,827 | $63.2K | — |